Using QQ plots and a univariate correlation test (Johnson and Wichern, 1998), we found these data not to be approximately normal nor consistently transformable to approximate normality for all three datasets (HC, BL, 4w)
Daily Dose: 2.67 mg (equivalent to 10 units / 0.10 mL), maintained throughout the full cycle Frequency: Administer once daily via subcutaneous injection, ideally at the same time each day Cycle Duration: 4-16 weeks of continuous use, followed by a 24 week break to assess response and support receptor recovery Injection Volume: Approximately 0.10 mL per dose, well within typical comfort limits for subcutaneous delivery (generally under 1.01.5 mL) Syringe Guidance: A 0.3 mL (30-unit) U-100 insulin syringe is recommended for improved accuracy when measuring small volumes Storage Instructions Proper storage is essential to maintain peptide stability and integrity
Together with dietary antioxidants such as Vitamin C, Vitamin E, melatonin, and carotenoids [63, 64], these antioxidant systems serve as free radical scavengers by preventing, buffering, and repairing damages caused by OS, and enhancing the immune defense against degenerative diseases [65] (Fig
In the myocardium, a reduction in LOX activity disrupts the connective tissue architecture and impairs contractile function [47]
Determination of the effect of different leonurine doses on early embryonic development Initially, different concentrations of leonurine were supplemented to the culture medium during the in vitro culture phase, and the optimal leonurine concentration in terms of embryo development and blastocyst formation rates (numbers of blastocysts/numbers of presumptive zygotes taken into culture medium x 100) were identified (Fig
